论文部分内容阅读
目的 :观察布地奈德气雾剂吸入治疗喘息性支气管炎临床效果。方法 :5 3例慢性喘息性支气管炎患者随机分为观察组 (2 9例 )、对照组 (2 4例 ) ,在抗感染、平喘等治疗的基础上观察组给予布地奈德气雾剂吸入治疗 6周。所有病例治疗前后测定第 1秒用力呼气容量 (FEV1)、用力肺活量 (FVC)、FEV1占FVC的百分数 (FEV1/FVC % )和最大呼气流量 (PEF) ,观察临床疗效。结果 :两组临床症状改善无明显差异 (P >0 .0 5 ) ,FEV1、FVC、FEV1/FVC %治疗前后变化显著 (P <0 .0 5 ) ,PEF变化不明显。对照组各项指标在治疗前后无显著变化 (P >0 .0 5 )。结论 :布地奈德吸入治疗喘息性支气管炎能够改善患者肺功能 ,但近期临床疗效不明显
Objective: To observe the clinical effect of budesonide aerosol inhalation in the treatment of asthmatic bronchitis. Methods: Fifty-three patients with chronic asthmatic bronchitis were randomly divided into observation group (29 cases) and control group (24 cases). On the basis of anti-infection and antiasthmatic treatment, the observation group was given budesonide aerosol Inhaled for 6 weeks. Before and after treatment, FEV1, FVC, FEV1 / FVC% and PEF were measured before and after treatment to observe the clinical effect. Results: There was no significant difference in clinical symptoms between the two groups (P> 0.05). FEV1, FVC and FEV1 / FVC% had significant changes before and after treatment (P <0.05), while PEF did not change significantly. The indexes of the control group showed no significant changes before and after treatment (P> 0.05). Conclusion: Budesonide inhalation for asthmatic bronchitis can improve pulmonary function, but the clinical effect is not obvious